Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathy.

Scientific reports·2026
Same author

miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer.

Journal of experimental & clinical cancer research : CR·2025
Same author

Clinical outcomes in Fabry patients switching to agalsidase beta for renal ineffectiveness of the primary Fabry therapy: a single-centre analysis.

Clinical kidney journal·2025
Same author

Parent, Child, and Provider Perspectives on HPV Vaccination in 4-8-Year-Olds: A Mixed Methods Study.

Journal of cancer education : the official journal of the American Association for Cancer Education·2025
Same author

Is segmental/multifocal onset a distinct presentation of idiopathic adult-onset dystonia?

Journal of the neurological sciences·2025
Same author

Patterns of Left Ventricular Remodeling and Outcomes in Fabry Disease.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2025
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
10:05

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

Published on: January 27, 2018

10.2K

Dystonia.

Bettina Balint1,2, Niccolò E Mencacci3, Enza Maria Valente4,5

  • 1Sobell Department of Motor Neuroscience and Movement Disorders,, UCL Institute of Neurology, UCL, London, UK.

Nature Reviews. Disease Primers
|September 22, 2018
PubMed
Summary
This summary is machine-generated.

Dystonia is a neurological disorder causing involuntary muscle contractions and postures. Understanding genetic and idiopathic causes reveals abnormal brain circuit mechanisms, aiding future treatment development.

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

8.0K
Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress
06:38

Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress

Published on: January 23, 2019

20.3K

Related Experiment Videos

Last Updated: Feb 5, 2026

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
10:05

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

Published on: January 27, 2018

10.2K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

8.0K
Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress
06:38

Low-cost Protocol of Footprint Analysis and Hanging Box Test for Mice Applied the Chronic Restraint Stress

Published on: January 23, 2019

20.3K

Area of Science:

  • Neurology
  • Genetics
  • Neuroscience

Background:

  • Dystonia is a neurological disorder characterized by involuntary muscle contractions and abnormal postures.
  • It can manifest as isolated dystonia or combined with other neurological signs.
  • This primer focuses on idiopathic and genetic forms of isolated dystonia, affecting all ages and causing significant disability.

Purpose of the Study:

  • To provide an overview of isolated dystonia, focusing on idiopathic and genetic etiologies.
  • To explore the underlying pathophysiology, including genetic mutations and neurobiological mechanisms.
  • To discuss current diagnostic challenges and available symptomatic treatments.

Main Methods:

  • Review of existing literature on dystonia, focusing on genetic and idiopathic forms.
  • Analysis of known genetic mutations (e.g., TOR1A, THAP1, GCH1, KMT2B) and their impact on pathophysiology.
  • Summary of clinical diagnostic criteria and current therapeutic interventions.

Main Results:

  • Genetic discoveries have elucidated pathophysiology, involving abnormalities in transcriptional regulation, dopaminergic signaling, synaptic plasticity, and neuronal circuit inhibition.
  • Common genetic dystonias are linked to specific gene mutations, providing insights into disease mechanisms.
  • Current treatments include anticholinergics, botulinum toxin, and deep brain stimulation, offering symptomatic relief.

Conclusions:

  • Understanding the genetic basis of dystonia has improved insights into its complex pathophysiology.
  • Diagnosis remains challenging, relying primarily on clinical signs.
  • While effective symptomatic treatments exist, future research aims for reliable biomarkers, improved therapies, and a potential cure for dystonia.